Use of extracorporeal blood purification therapy (ECBPT) as an adjuvant to high-dose corticosteroids in a severely ill COVID-19 patient with concomitant bacterial infection

• 主要な著者: Min Xian Lim, Kean Khang Fong, Yeap, Boon Tat
• フォーマット: 論文
• 言語: English; English
• 出版事項: BMJ Publishing Group 2021
• 主題: RA1-1270 Public aspects of medicine
• オンライン･アクセス: https://eprints.ums.edu.my/id/eprint/33040/1/Use%20of%20extracorporeal%20blood%20purification%20therapy%20%28ECBPT%29%20as%20an%20adjuvant%20to%20high-dose%20corticosteroids%20in%20a%20severely%20ill%20COVID-19%20patient%20with%20concomitant%20bacterial%20infection.pdf; https://eprints.ums.edu.my/id/eprint/33040/2/Use%20of%20extracorporeal%20blood%20purification%20therapy%20%28ECBPT%29%20as%20an%20adjuvant%20to%20high-dose%20corticosteroids%20in%20a%20severely%20ill%20COVID-19%20patient%20with%20concomitant%20bacterial%20infection%20_ABSTRACT.pdf; https://eprints.ums.edu.my/id/eprint/33040/; https://casereports.bmj.com/content/bmjcr/14/10/e245639.full.pdf; https://doi.org/10.1136/bcr-2021-245639

COVID-19 presents with a spectrum of severity, ranging from asymptomatic or mild symptoms to those with acute respiratory distress syndrome. Corticosteroids are widely used for their efficacy in reducing inflammatory responses. However, its use may be limited to patients with immunosuppression. An a...